Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

TriSalus Life Sciences (TLSI) Change in Intangibles (2022 - 2023)

TriSalus Life Sciences has reported Change in Intangibles over the past 2 years, most recently at $328000.0 for Q4 2023.

For Q4 2023, Change in Intangibles rose 382.35% year-over-year to $328000.0; the TTM value through Jun 2024 reached $467000.0, changed N/A, while the annual FY2023 figure was $533000.0, 306.87% up from the prior year.
Change in Intangibles for Q4 2023 was $328000.0 at TriSalus Life Sciences, up from $139000.0 in the prior quarter.
Over five years, Change in Intangibles peaked at $328000.0 in Q4 2023 and troughed at -$1000.0 in Q2 2023.